Global Blood and Blood-Forming Organs Diseases Mortality by Country

The United States shows the highest mortality rate for blood and blood-forming organs diseases among the listed countries, with a marginal increase of 0.79% year-on-year. Latin American countries like Colombia and Mexico experience rising mortalities, potentially due to developing healthcare infrastructures. Meanwhile, European countries such as Latvia and Slovakia report significant decreases in death rates, indicative of improved medical interventions and healthcare systems. Stable or slight negative growth in Western European nations and Canada suggests well-established healthcare systems managing these diseases effectively.

Future trends to watch include:

- Technological advancements in treatment and early diagnosis could further reduce mortality rates globally.- Emerging health policies and access to healthcare will play crucial roles, especially in developing countries with higher mortality.- Close monitoring of demographic shifts, as aging populations in developed regions could impact disease prevalence and mortality.- Implementation of global health initiatives may bring focused efforts on disease management and reduction across different regions.

Top countries in Blood and Blood-Forming Organs Diseases Mortality by Country

# 10 Countries Units (Female Deaths) Last Year YoY 5-years CAGR
1 1 United States 6,110 2023 +0.88% +0.79% View data
2 2 South Africa 4,160 2023 -4.19% -3.25% View data
3 3 Brazil 3,460 2023 +0.84% +0.24% View data
4 4 Mexico 2,640 2023 -0.49% +2.83% View data
5 5 Japan 2,450 2023 +0.86% +0.45% View data
6 6 Spain 1,240 2023 +1.3% +3.25% View data
7 7 Argentina 909 2023 +5.21% +3.08% View data
8 8 Colombia 684 2023 +4.75% +12.3% View data
9 9 United Kingdom 670 2023 -1.03% -0.35% View data
10 10 Peru 582 2023 +1.78% +2.65% View data

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease